Document Detail


Enhancement of the innate and cellular immune response in patients with genital warts treated with topical imiquimod cream 5%.
MedLine Citation:
PMID:  10480263     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The mechanism of action of imiquimod 5% cream applied topically to patients with genital warts was evaluated in a double-blind, placebo-controlled study. Imiquimod (16 patients) or placebo (three patients) was applied three times per week for up to 16 weeks. All imiquimod-treated patients had a > or =75% reduction in total wart area while only one of three placebo-treated patients had a similar reduction. Wart biopsies were taken at prestudy, week 6, and end of treatment. Polymerase chain reaction (PCR) for human papillomavirus (HPV) DNA and reverse transcriptase (RT)-PCR for messenger (m)RNAs were used to identify cytokines, cellular markers, viral gene products, and cell cycle markers in these biopsies. Treatment with imiquimod, an immune response modifier, stimulated significant increases in mRNA for interferon (IFN)-alpha, IFN-gamma and 2',5' oligoadenylate synthetase (2',5'-AS) as well as a tendency towards increases in tumor necrosis factor (TNF)-alpha and interleukin-12 p40. Significant increases in mRNA for CD4 and a trend toward increases in CD8 were also observed in imiquimod-treated patients, suggesting activation of a cell mediated immune response. Imiquimod administration was also associated with a significant decrease in viral load as measured by HPV DNA and L1 mRNA. The effects on HPV markers were accompanied by an apparent decrease in mRNA expression for markers of cell proliferation and an increase in mRNA for markers of keratinocyte differentiation and tumor suppressors.
Authors:
I Arany; S K Tyring; M A Stanley; M A Tomai; R L Miller; M H Smith; D J McDermott; H B Slade
Related Documents :
15313193 - Regulated transcripts in the hippocampus following transections of the entorhinal affer...
19046253 - Molecular mechanisms of il-18bp regulation in dld-1 cells: pivotal direct action of the...
9311583 - Constitutive co-expression of estrogen and progesterone receptor mrna in human meningio...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Antiviral research     Volume:  43     ISSN:  0166-3542     ISO Abbreviation:  Antiviral Res.     Publication Date:  1999 Aug 
Date Detail:
Created Date:  1999-11-01     Completed Date:  1999-11-01     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8109699     Medline TA:  Antiviral Res     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  55-63     Citation Subset:  IM; X    
Affiliation:
Department of Microbiology and Immunology, The University of Texas Medical Branch at Galveston, 77555-1019, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aminoquinolines / therapeutic use*
Antigens, CD / genetics,  metabolism
Cell Differentiation
Cell Division
Condylomata Acuminata / drug therapy*,  immunology,  virology
Cytokines / genetics,  metabolism
Double-Blind Method
Female
Genital Diseases, Female / drug therapy*,  immunology,  virology
Genital Diseases, Male / drug therapy*,  immunology,  virology
Humans
Interferon Inducers / therapeutic use*
Keratinocytes / pathology
Male
Middle Aged
Papillomaviridae / genetics,  isolation & purification,  physiology
Polymerase Chain Reaction
RNA, Messenger / metabolism
Viral Load
Chemical
Reg. No./Substance:
0/Aminoquinolines; 0/Antigens, CD; 0/Cytokines; 0/Interferon Inducers; 0/RNA, Messenger; 99011-02-6/imiquimod

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Synthesis and antiviral activity of phosphoralaninate derivatives of methylenecyclopropane analogues...
Next Document:  In situ imaging of microorganisms in geologic material.